Obesity Phenotypes, Diabetes, and Cardiovascular Diseases

Obesity is one of the most significant risk factors for cardiovascular disease and diabetes, yet research increasingly shows that not all obesity carries the same metabolic risk. This influential review by Piché, Tchernof, and Després, published in Circulation Research, explored how different obesity phenotypes relate to diabetes and cardiovascular disease outcomes.

The authors analyzed the existing body of evidence on obesity classification, examining how factors like visceral fat distribution, ectopic fat deposition, and adipose tissue dysfunction contribute to metabolic risk profiles. They assessed the clinical relevance of distinguishing between metabolically healthy and metabolically unhealthy obesity phenotypes.

The findings revealed that obesity phenotypes vary significantly in their association with cardiometabolic risk. Visceral and ectopic fat accumulation, rather than total body fat alone, emerged as the primary drivers of insulin resistance, dyslipidemia, and cardiovascular events. This distinction is critical because it suggests that interventions targeting specific fat metabolism pathways may be more effective than general weight loss strategies.

For the field of metabolic health, this review reinforces the importance of precision approaches to obesity treatment. Compounds that target specific metabolic enzymes involved in fat storage and energy balance, such as NNMT inhibitors like 5-Amino-1MQ, align well with this phenotype-driven approach by addressing the underlying metabolic dysfunction rather than simply reducing total body weight.